Archivio Istituzionale della RicercaAlthough a 1-year duration of dual antiplatelet therapy (DAPT) is used in many patients after drug-eluting stent (DES) implantation, the evidence supporting this duration is uncertain.
Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk / Palmerini, Tullio; Bruno, Antonio Giulio; Redfors, Björn; Valgimigli, Marco; Taglieri, Nevio; Feres, Fausto; Abizaid, Alexandre; Costa, Ricardo; Gilard, Martine; Morice, Marie-Claude; Hong, Myeong-Ki; Kim, Byeong-Keuk; Jang, Yangsoo; Kim, Hyo-Soo; Park, Kyung Woo; Colombo, Antonio; Chieffo, Alaide; Nakamura, Masato; Kotinkaduwa, Lak N; Nardi, Elena; Saia, Francesco; Gasparini, Mauro; Rizzello, Giulia; Weisz, Giora; Kirtane, Ajay J; Mehran, Roxana; Witzenbichler, Bernhard; Galiè, Nazzareno; Stone, Gregg W. - In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. - ISSN 1558-3597. - 78:20(2021), pp. 1968-1986. [10.1016/j.jacc.2021.08.070]
Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk
Gasparini, Mauro;
2021
Abstract
Although a 1-year duration of dual antiplatelet therapy (DAPT) is used in many patients after drug-eluting stent (DES) implantation, the evidence supporting this duration is uncertain.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk.pdf
non disponibili
Tipologia:
2a Post-print versione editoriale / Version of Record
Licenza:
Non Pubblico - Accesso privato/ristretto
Dimensione
2.11 MB
Formato
Adobe PDF
|
2.11 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11583/2970080